Quarterly report pursuant to Section 13 or 15(d)

Consolidated Condensed Balance Sheets

v3.23.3
Consolidated Condensed Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 7,621 $ 11,144
Short-term investments 17,409 17,194
Accounts receivable, net 2,843 4,133
Inventories 11,466 13,224
Other current assets 4,472 4,712
Total current assets 43,811 50,407
Property, plant, and equipment, net of accumulated depreciation of $97,122 ($93,386 as of December 31, 2022) 93,352 80,860
Equity Investments 5,700 5,912
Goodwill 27,591 27,591
Identified intangible assets, net 4,970 6,018
Other long-term assets 13,413 11,315
Total assets 188,837 182,103
Current liabilities:    
Short-term debt 2,288 4,367
Accounts payable 8,669 9,595
Accrued compensation and benefits 3,115 4,084
Income taxes payable 2,112 2,251
Other accrued liabilities 12,430 11,858
Total current liabilities 28,614 32,155
Debt 46,591 37,684
Other long-term liabilities 7,946 8,978
Contingencies (Note 13)
Stockholders’ equity:    
Common stock and capital in excess of par value, 4,216 issued and outstanding (4,137 issued and outstanding as of December 31, 2022) 35,653 31,580
Accumulated other comprehensive income (loss) (861) (562)
Retained earnings 67,021 70,405
Total stockholders' equity 101,813 101,423
Non-controlling interest 3,873 1,863
Accumulated other comprehensive income (loss) 105,686 103,286
Total liabilities and stockholders’ equity $ 188,837 $ 182,103